Personalized Approaches to Spine Surgery

Footnotes

• Funding The authors received no financial support for the research, authorship, and/or publication of this article.

• Declaration of Conflicting Interests The authors report no conflicts of interest in this work.

• Editor’s Note Editor’s Note: This article is an addendum to the August 2024 IJSS special issue on personalized medicine in spine surgery. View the full special issue at https://www.ijssurgery.com/content/18/S1.

• Disclosures P.V.M. serves as a consultant for DePuy Spine and Globus, has direct stock ownership in Discgenics, receives royalties from Thieme Publishers and Springer Publishing, has received support from ISSG, NREF, AOSpine, NIH, PCORI, SLIP II, Pacira, and DoD for nonstudy-related clinical or research effort, and receives honoraria from BK Medical, Brainlab, and SI Bone. E.C.H. serves in an unpaid capacity on the Medical Registry Advisory Board of the International Fibrodysplasia Ossificans Progressiva Association; the Fibrous Dysplasia Foundation Medical Advisory Board; and the International Clinical Council on FOP. E.C.H. also receives clinical trials support through his institution from Clementia Pharmaceuticals, an Ipsen Company; Ipsen Pharmaceuticals; Ascendis Bio; and ashibio.